MedPath

广州白云山中一药业有限公司

Ownership
-
Established
1959-09-24
Employees
-
Market Cap
-
Website
https://www.gz111.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

142

NMPA:142

Drug Approvals

蛤蚧定喘丸

Approval Number
国药准字Z44020052
Approval Date
Apr 26, 2024
NMPA

复方南板蓝根片

Approval Number
国药准字Z44020263
Approval Date
Apr 26, 2024
NMPA

感冒止咳颗粒

Approval Number
国药准字Z44022537
Approval Date
Apr 26, 2024
NMPA

归脾丸

Approval Number
国药准字Z44020053
Approval Date
Apr 26, 2024
NMPA

红花跌打丸

Approval Number
国药准字Z44020055
Approval Date
Apr 26, 2024
NMPA

六味地黄丸

Approval Number
国药准字Z44020243
Approval Date
Apr 19, 2024
NMPA

复方丹参片

Approval Number
国药准字Z20113069
Approval Date
Apr 9, 2024
NMPA

治咳片

Approval Number
国药准字Z44022462
Approval Date
Apr 9, 2024
NMPA

银翘解毒颗粒

Approval Number
国药准字Z20083140
Approval Date
Apr 9, 2024
NMPA

归脾丸

Approval Number
国药准字Z44020040
Approval Date
Apr 9, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 15
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.